Les médicaments contre le cancer en Inde pourraient baisser de 20 à 70 % après l'approbation de la NPPA | News18

La NPPA a approuvé en principe un plafonnement de la marge commerciale à 30 % du prix de vente maximum. Selon le reportage, le prix de nombreux médicaments anticancéreux pourrait baisser de 20 à 70 %.

Many cancer medicines in India could become much cheaper, with prices falling by 20 to 70 per cent, after the government’s drug pricing watchdog, the National Pharmaceutical Pricing Authority (NPPA), approved a cap on how much sellers can add to the price between the factory and the patient. The authority has approved in principle a proposal to cap this difference, called the trade margin, at 30 per cent of the maximum retail price (MRP), the price printed on the pack. The government estimates that patients will save about Rs 2,500 crore a year. #CancerMedicines #CancerTreatment #NPPA #Healthcare #DrugPrices #IndiaNews #BreakingNews #CancerCare #CNNNews18 n18oc_breaking-news